Olongapo village exec tests positive for COVID-19 days after death | Inquirer News

Olongapo village exec tests positive for COVID-19 days after death

SAN ANTONIO, ZAMBALES – A village official of Olongapo City, who died on Nov. 4 from an affliction related to a spinal condition, has tested positive for the coronavirus disease (COVID-19).

The unnamed 69-year-old man, who is an official of Barangay (village) New Banicain, died from a “neurogenic shock secondary to CVD bleed vs infarct,” according to a Nov. 6 statement from Olongapo Mayor Rolen Paulino Jr.

The man was rushed to the city hospital after complaining of abdominal pains, as well as breathing difficulties, on October 31. He underwent a reverse transcription polymerase chain reaction (RT-PCR) test on Monday (Nov. 2), but died two days after.

The latest fatality raises the number of COVID-19 related deaths in Olongapo to 29. With 11 new infections, the city now has 854 total number of COVID-19 cases. About 758 patients have since recovered.

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo City

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.